95 related articles for article (PubMed ID: 22196969)
21. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
22. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
[TBL] [Abstract][Full Text] [Related]
23. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
[TBL] [Abstract][Full Text] [Related]
24. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.
Sasse EC; Sasse AD; Brandalise S; Clark OA; Richards S
Cochrane Database Syst Rev; 2005 Jul; (3):CD004139. PubMed ID: 16034921
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
26. Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma.
O'Day SJ; Atkins MB; Boasberg P; Wang HJ; Thompson JA; Anderson CM; Gonzalez R; Lutzky J; Amatruda T; Hersh EM; Weber JS
J Clin Oncol; 2009 Dec; 27(36):6207-12. PubMed ID: 19917850
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.
van Besien K; Rodriguez A; Tomany S; Younes A; Donato M; Sarris A; Giralt S; Mehra R; Andersson B; Gajewski J; Champlin R; Cabanillas F
Bone Marrow Transplant; 2001 Feb; 27(4):397-404. PubMed ID: 11313669
[TBL] [Abstract][Full Text] [Related]
28. Improving results of autologous stem cell transplantation for Philadelphia-positive acute lymphoblastic leukaemia in the era of tyrosine kinase inhibitors: a report from the Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.
Giebel S; Labopin M; Gorin NC; Caillot D; Leguay T; Schaap N; Michallet M; Dombret H; Mohty M
Eur J Cancer; 2014 Jan; 50(2):411-7. PubMed ID: 24210524
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum during induction treatment of acute leukaemia.
Sallerfors B; Olofsson T
Br J Haematol; 1991 Jul; 78(3):343-51. PubMed ID: 1714757
[TBL] [Abstract][Full Text] [Related]
30. [Results of treatment of acute lymphoblastic leukemia in two cohorts of Mexican patients].
Ramos C; Rozen E; León M; Martínez T A; Olarte I; Catellanos H; Martínez C; Montaño E; Kassack I J; Zamora J; Miranda E; De la Ros A; Gutiérrez M; Collazo J
Rev Med Chil; 2011 Sep; 139(9):1135-42. PubMed ID: 22215391
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study.
Usuki K; Urabe A; Masaoka T; Ohno R; Mizoguchi H; Hamajima N; Miyazaki T; Niitsu Y; Yoshida Y; Miura A; Shibata A; Abe T; Miura Y; Ikeda Y; Nomura T; Nagao T; Saitou H; Shirakawa S; Ohkuma M; Matsuda T; Nakamura T; Horiuchi A; Kuramoto A; Kimura I; Irino S; Niho Y; Takatsuki K; Tomonaga M; Uchino H; Takaku F;
Br J Haematol; 2002 Jan; 116(1):103-12. PubMed ID: 11841402
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs.
Bassan R; Lerede T; Di Bona E; Rossi G; Pogliani E; Rambaldi A; Buelli M; Viero P; Rodeghiero F; Izzi T; Corneo G; Barbui T
Leuk Lymphoma; 1997 Jun; 26(1-2):153-61. PubMed ID: 9250800
[TBL] [Abstract][Full Text] [Related]
33. G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: a randomized multicenter study.
Hołowiecki J; Giebel S; Krzemień S; Krawczyk-Kuliś M; Jagoda K; Kopera M; Hołowiecka B; Grosicki S; Hellmann A; Dmoszyńska A; Paluszewska M; Robak T; Konopka L; Maj S; Wojnar J; Wojciechowska M; Skotnicki A; Baran W; Cioch M
Leuk Lymphoma; 2002 Feb; 43(2):315-25. PubMed ID: 11999563
[TBL] [Abstract][Full Text] [Related]
34. Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party.
Wheatley K; Goldstone AH; Littlewood T; Hunter A; Burnett AK
Br J Haematol; 2009 Jun; 146(1):54-63. PubMed ID: 19438472
[TBL] [Abstract][Full Text] [Related]
35. Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival.
Tjønnfjord GE; Gedde-Dahl T; Heldal D; Brinch L
Leukemia; 2007 Oct; 21(10):2203-4. PubMed ID: 17525727
[No Abstract] [Full Text] [Related]
36. Impact of granulocyte colony stimulating factor administered during induction and consolidation of adults with acute lymphoblastic leukemia on survival: long-term follow-up of the Polish adult leukemia group 4-96 study.
Giebel S; Holowiecki J; Krawczyk-Kulis M; Jagoda K; Stella-Holowiecka B; Sadus-Wojciechowska M; Hellmann A; Dmoszynska A; Paluszewska M; Robak T; Konopka L; Seferynska I; Skotnicki AB; Kyrcz-Krzemien S
Leuk Lymphoma; 2009 Jun; 50(6):1050-3. PubMed ID: 19455463
[No Abstract] [Full Text] [Related]
37. Efficacy of mitoxantrone as frontline anthracycline during induction therapy in adults with newly diagnosed acute lymphoblastic leukemia: a single-center experience.
Jaime-Perez JC; Colunga-Pedraza PR; Gutiérrez-Aguirre CH; Pinzón-Uresti MA; Cantú-Rodríguez OG; Herrera-Garza JL; Gómez-Almaguer D
Leuk Lymphoma; 2015; 56(9):2524-8. PubMed ID: 25629985
[TBL] [Abstract][Full Text] [Related]
38. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis.
Ram R; Wolach O; Vidal L; Gafter-Gvili A; Shpilberg O; Raanani P
Am J Hematol; 2012 May; 87(5):472-8. PubMed ID: 22388572
[TBL] [Abstract][Full Text] [Related]
39. The effect of granulocyte colony-stimulating factors on survival parameters in pediatric patients with acute lymphoblastic leukemia: A retrospective study.
Tekgunduz SA; Aycicek A; Bayram C; Uysalol EP; Akici F; Ozdemir GN
Transfus Apher Sci; 2022 Feb; 61(1):103366. PubMed ID: 35120829
[TBL] [Abstract][Full Text] [Related]
40. The role of colony-stimulating factors in the treatment of acute leukaemia.
Harousseau JL
BioDrugs; 1997 Jun; 7(6):448-60. PubMed ID: 18020493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
